• Client Reporting Portal
  • For Managers
  • Contact Us
Xponance | Asset Management and Investment
  • Strategies
    • Multi-Manager Platform
    • Systematic Global Equities
      • Active Strategies
        • Market Plus
        • SMID Cap Core
        • Small Cap Core
      • Passive Strategies
        • S&P 500 Index Replication
        • S&P 400 Index Replication
        • Russell 1000 Index Replication
        • Russell 1000 Growth Index Replication
        • Russell 1000 Value Index Replication
        • Russell 3000 Index Replication
        • MSCI World ex US
        • MSCI USA
      • Values-Based Equity
        • S&P 500 ESG Enhanced
        • S&P 500 DEI & ESG
      • Customized Mission Aligned
        • S&P 500 Catholic Values
    • U.S. Fixed Income
      • Limited Duration
      • Opportunistic Core
      • Intermediate Government/Credit
    • Xponance Alts
    • Values-Based Investing
  • Perspectives
    • Insights
    • Archives
      • Foresights
      • Global Market Outlook Reports
      • Market Insights Alerts
      • Videos And Webinars
  • News
    • Newsroom – Press Releases
    • Media Coverage
  • About Xponance®
    • Company
    • Mission
    • People
      • Executive
      • Investment Leaders
      • Portfolio Operations
      • Corporate
      • Sales & Client Service
      • Xponance Alts
      • Board of Directors
    • Careers
    • Emerging Manager Ecosystem
    • Community Engagement
Select Page

Home » X Vendor Logo Development Page

Philadelphia

Headquarters
1845 Walnut Street
Suite 800
Philadelphia PA 19103
215.567.1100

Durham, NC

2605 Meridian Parkway
Suite 105
Durham, NC 27713
919.688.8600

Sign Up For Email Updates

Contact Us

Strategies

Multi-Manager Platform
Systematic Global Equities
U.S. Fixed Income

Perspectives

Insights
Archive Foresight
Archive Global Market Outlook Reports

News

Media Coverage
Press Releases

About Xponance®

Company
Mission
People
Emerging Manager Ecosystem
Community Engagement

Terms of Use | Privacy Policy | Careers | Form CRS | ADV Part 2A | ADV Part 2B | 408(b)(2)

  • Follow
  • Follow
  • Follow

©2006 – 2024, Xponance®, Inc. and/or its predecessor companies; XPONANCE®, TRANSFORMING ACCESS TO ALPHA and AAPRYL® are registered trademarks of Xponance®, Inc. and/or its predecessor companies. All rights reserved.